- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
Patent holdings for IPC class A61K 51/10
Total number of patents in this class: 2229
10-year publication summary
|
170
|
173
|
172
|
175
|
181
|
161
|
199
|
182
|
200
|
55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Actinium Pharmaceuticals Inc. | 134 |
87 |
| Genentech, Inc. | 3961 |
57 |
| Memorial Sloan-Kettering Cancer Center | 1910 |
52 |
| Cornell University | 3284 |
40 |
| The Regents of the University of California | 19812 |
39 |
| Nihon Medi-physics Co., Ltd. | 181 |
38 |
| Janssen Biotech, Inc. | 1531 |
36 |
| Immunomedics, Inc. | 267 |
34 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
33 |
| Fusion Pharmaceuticals Inc. | 88 |
31 |
| F. Hoffmann-La Roche AG | 7926 |
30 |
| The University of British Columbia | 1492 |
30 |
| Bayer AS | 37 |
25 |
| Mayo Foundation for Medical Education and Research | 3188 |
24 |
| Astellas Pharma Inc. | 1086 |
21 |
| Immatics Biotechnologies GmbH | 1152 |
20 |
| Centre National de La Recherche Scientifique | 10321 |
19 |
| Vrije Universiteit Brussel | 497 |
19 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
17 |
| Telix Pharmaceuticals (innovations) Pty Ltd | 26 |
17 |
| Other owners | 1560 |